USAF Ge-1 en es it fr

USAF Ge-1 Brand names, USAF Ge-1 Analogs

USAF Ge-1 Brand Names Mixture

  • No information avaliable

USAF Ge-1 Chemical_Formula

C11H15NO

USAF Ge-1 RX_link

No information avaliable

USAF Ge-1 fda sheet

USAF Ge-1 msds (material safety sheet)

USAF_Ge-1 MSDS

USAF Ge-1 Synthesis Reference

No information avaliable

USAF Ge-1 Molecular Weight

177.243 g/mol

USAF Ge-1 Melting Point

139 oC

USAF Ge-1 H2O Solubility

>5 mg/L

USAF Ge-1 State

Solid

USAF Ge-1 LogP

1.796

USAF Ge-1 Dosage Forms

Tablet

USAF Ge-1 Indication

Used as an anorectic in the treatment of obesity.

USAF Ge-1 Pharmacology

Phenmetrazine is a sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. Phenmetrazine was originally sold under the tradename Preludin as an anorectic. It has since been removed from the market. It is by some considered to have a greater potential for addiction than the amphetamines, and has been abused in many countries, for example Sweden.

USAF Ge-1 Absorption

Readily absorbed from the gastro-intestinal tract and buccal mucosa.

USAF Ge-1 side effects and Toxicity

Adult monkeys have an LD50 of 15 to 20 mg/kg, whereas for young monkeys the LD50 is only 5 mg/kg. Symptoms of overdose include acute central nervous system stimulation, cardiotoxicity causing tachycardia, arrhythmias, hypertension, and cardiovascular collapse. Whilst some patients show signs of toxicity at blood concentrations of 20 µg/L, chronic abusers of amphetamine have been known to have blood concentration of up to 3000 µg/L.

USAF Ge-1 Patient Information

No information avaliable

USAF Ge-1 Organisms Affected

Humans and other mammals